the combination of the lipophilic antifolate trimetrexate and the rescue agent leucovorin has shown promise in the treatment of pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome .
C0085176
trimetrexate
C1535939
pneumocystis carinii pneumonia